Synthesis, In Vitro Evaluation and Molecular Docking Studies of Novel Thiophenyl Thiazolyl-Pyridine Hybrids as Potential Anticancer Agents
Molecules · 23.05.2023 · 28 (11) · 4270
DOI: 10.3390/molecules28114270 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 23.05.2023. Verfasst von Fayza O Ashmawy und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Biochemistry Division, Faculty of Science, Cairo University, Giza 12613, Egypt. Hauptthemen laut MEDLINE: Antineoplastic Agents, Lung Neoplasms. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Many literature reports revealed the anticancer activity of pyridine and thiazole derivatives, especially in lung cancer. Therefore, a new series of thiazolyl pyridines linked with thiophene moiety via hydrazone group was prepared by one-pot multi-component reaction of (E)-1-(4-methyl-2-(2-(1-(thiophen-2-yl)ethylidene)hydrazinyl)thiazol-5-yl)ethanone with benzaldehyde derivatives and malononitrile in a good yield. Then, compound 5 and the thiazolyl pyridines were investigated for their in vitro anticancer activity against lung cancer (A549) cell line using MTT assay compared to doxorubicin as a reference drug. The structure of all the newly synthesized compounds was established based on spectroscopic data and elemental analyses. For better insight to investigate their mechanism of action on A549 cell line, docking studies were performed, targeting epidermal growth factor receptor (EGFR) tyrosine kinase. The results obtained revealed that the tested compounds displayed excellent anticancer activities against lung cancer cell line except 8c and 8f compared to reference drug. Based on the data obtained, it can be inferred that the novel compounds, as well as their key intermediate, compound 5, demonstrated potent anticancer activity against lung carcinoma by inhibiting EGFR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Biochemistry Division, Faculty of Science, Cairo University, Giza 12613, Egypt.
- Department of Chemistry, Faculty of Science, Islamic University of Madinah, Madinah 42351, Saudi Arabia.
- Department of Chemistry, Faculty of Science, Cairo University, Giza 12613, Egypt.
- Department of Chemistry, Faculty of Science, Imam Mohammed Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi Arabia.
ORCID-Profile: Sobhi M Gomha, Magdi E A Zaki, Sami A Al-Hussain, Mohamed A El-Desouky
Zitieren
APA
Ashmawy, F. O., Gomha, S. M., Abdallah, M. A., Zaki, M. E. A., Al-Hussain, S. A., & El-Desouky, M. A. (2023). Synthesis, In Vitro Evaluation and Molecular Docking Studies of Novel Thiophenyl Thiazolyl-Pyridine Hybrids as Potential Anticancer Agents. Molecules, 28(11), 4270. https://doi.org/10.3390/molecules28114270
Vancouver
Ashmawy FO, Gomha SM, Abdallah MA, Zaki MEA, Al-Hussain SA, El-Desouky MA. Synthesis, In Vitro Evaluation and Molecular Docking Studies of Novel Thiophenyl Thiazolyl-Pyridine Hybrids as Potential Anticancer Agents. Molecules. 2023;28(11):4270. doi:10.3390/molecules28114270
BibTeX
@article{Ashmawy2023,
author = {Ashmawy, Fayza O and Gomha, Sobhi M and Abdallah, Magda A and Zaki, Magdi E A and Al-Hussain, Sami A and El-Desouky, Mohamed A},
title = {Synthesis, In Vitro Evaluation and Molecular Docking Studies of Novel Thiophenyl Thiazolyl-Pyridine Hybrids as Potential Anticancer Agents},
journal = {Molecules},
year = {2023},
volume = {28},
number = {11},
pages = {4270},
doi = {10.3390/molecules28114270}
}
EUVIMED